1. Al Mahri, S., S.S. Malik, M. Al Ibrahim, E. Haji, G. Dairi and S. Mohammad, 2022. Free Fatty Acid Receptors (FFARs) in adipose: Physiological role and therapeutic outlook. Cells, Vol. 11. 10.3390/cells11040750 .
   CrossRef  |  Direct Link  |  
2. Mohammad, S., R. Aziz, S. Al Mahri, S.S. Malik and E. Haji et al., 2021. Obesity and COVID-19: what makes obese host so vulnerable? Immun. Ageing, Vol. 18. 10.1186/s12979-020-00212-x.
   CrossRef  |  Direct Link  |  
3. Haji, E., S. Al Mahri, Y. Aloraij, S.S. Malik and S. Mohammad, 2021. Functional characterization of the obesity-linked variant of the β3-adrenergic receptor. Int. J. Mol. Sci., Vol. 22. 10.3390/ijms22115721.
   CrossRef  |  Direct Link  |  
4. Gupta, M.K., M. Beg and S. Mohammad, 2021. Editorial: Cell biology, physiology and molecular pharmacology of G protein coupled receptors. Front. Cell Dev. Biol., Vol. 9. 10.3389/fcell.2021.815291.
   CrossRef  |  Direct Link  |  
5. Mohammad, S., A. Bouchama, B.M. Alharbi, M. Rashid, T.S. Khatlani, N.S. Gaber and S.S. Malik, 2020. SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic divergence and functional convergence. Pathogens, Vol. 9. 10.3390/pathogens9090677.
   CrossRef  |  Direct Link  |  
6. Haji, E., S. Al Mahri, Y. Aloraij, S. Malik and S. Mohammad, 2019. Single-cell analysis of β2-adrenergic receptor dynamics by quantitative fluorescence microscopy. Curr. Mol. Med., 20: 488-493.
   CrossRef  |  Direct Link  |  
7. Alhawiti, N.M., S. Al Mahri, M.A. Aziz, S.S. Malik and S. Mohammad, 2017. TXNIP in metabolic regulation: Physiological role and therapeutic outlook. Curr. Drug Targets, 18: 1095-1103.
   CrossRef  |  Direct Link  |  
8. Mohammad, S., 2016. GPR40 agonists for the treatment of type 2 diabetes mellitus: Benefits and challenges. Curr. Drug Targets, 17: 1292-1300.
   CrossRef  |  Direct Link  |  
9. Mohammad, S., 2015. Role of free fatty acid receptor 2 (FFAR2) in the regulation of metabolic homeostasis. Curr. Drug Targets, 16: 771-775.
   CrossRef  |  Direct Link  |  
10. Mohammad, S., R.T. Patel, J. Bruno, M.S. Panhwar, J. Wen and T.E. McGraw, 2014. A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity. Mol. Cell. Biol., 34: 3618-3629.
    CrossRef  |  Direct Link  |